IceCure Medical Ltd (ICCM) Tops Q1 EPS by 1c

IceCure Medical Ltd (NASDAQ: ICCM) reported Q1 EPS of ($0.08), $0.01 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $710 thousand versus the consensus estimate of $933.33 thousand.

For earnings history and earnings-related data on IceCure Medical Ltd (ICCM) click here.

You May Also Be Interested In

• IceCure Highlights New Peer-Reviewed Journal Article in Leading Surgery Journal, Demonstrating Cryoablation's Advantages Over Radiofrequency Ablation for Early-Stage Breast Cancer
• Goldman "broadly" raises estimates for LTL and truckload stocks
• IceCure cites journal article on cryoablation vs. RFA for breast cancer